Dermata Therapeutics, Inc. (DRMA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$7.86M
Year ended 2021-12-31
2020-12-31: -$3.17M2021-12-31: -$7.86M-$7.86M
2020-12-31 EBITDA (USD) 2021-12-31
Period endedEBITDAChange YoYSource filing
2021-12-31-$7.86Mn/m2023-02-21, From 2021-01-01
2020-12-31-$3.17Mn/a2022-03-28, From 2020-01-01